2Senin U, Cherubini A, Palumbo B, et al. Pharmaceutical treatment of cognitive disorders in Alzheimer' s disease. Funct Neurol 1997;12:202 - 11
3Raskind MA, Sadowsky CH, Sigmund WR, et al. Effect of tacrine on languae,praxis, and noncognitive behavioral problems in Alzheimer disease. Aech Neurol 1997: 54:40 - 836
4Breitner JC, Gau BA, Welsh KA, et al. Inverse association of anti-inflammatory treatments and Alzheimer' s disease: Initial results of a co-twin control study. Neurology 1994; 44:227 - 32
5Rich JB, Rasmusson DX, Folstein MF, et al . Nonsteroidal anti-inflammatory Drugs in Alzheimer' s disease. Neurology 1995; 45: 51 - 5
6McGeer PL, McGeer EG. Anti-inflammatory drugs in the fight against Alzheimer' s disease. Ann N Y Acad Sci 1996; 777:201 - 13
7De La Torre JC, Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Rev 2000; 34(2): 119
8Launer LJ. Demonstrating the case that Alzheimer's disease is a vascular disease:epidemiologic evidence. Aging Res Rev 2002; 1:61 -77
9De La Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002; 33:1152 - 62
